10:51 AM EDT, 03/24/2025 (MT Newswires) -- (Updates to add stock move in the headline and the first paragraph.)

Tonix Pharmaceuticals ( TNXP ) shares rose more than 38% in recent Monday trading after the company said the US Food and Drug Administration will not require an advisory committee meeting regarding its new drug application for TNX-102 SL, a product candidate to treat fibromyalgia.

The biopharmaceutical company said the drug candidate is on track to meet the FDA's Prescription Drug User Fee Act goal of Aug. 15.

Price: 31.91, Change: +8.88, Percent Change: +38.56